Jane Street’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-70,516
| Closed | -$7.19M | – | 5934 |
|
|
2023
Q2 | $7.19M | Sell |
70,516
-8,527
| -11% | -$869K | ﹤0.01% | 1211 |
|
|
2023
Q1 | $7.19M | Buy |
79,043
+27,418
| +53% | +$2.49M | ﹤0.01% | 923 |
|
|
2022
Q4 | $1.96M | Buy |
+51,625
| New | +$1.96M | ﹤0.01% | 2018 |
|
|
2022
Q3 | – | Sell |
-76,351
| Closed | -$2.32M | – | 6563 |
|
|
2022
Q2 | $2.32M | Buy |
76,351
+61,622
| +418% | +$1.87M | ﹤0.01% | 1797 |
|
|
2022
Q1 | $483K | Buy |
14,729
+707
| +5% | +$23.2K | ﹤0.01% | 3803 |
|
|
2021
Q4 | $370K | Buy |
14,022
+9,439
| +206% | +$249K | ﹤0.01% | 3785 |
|
|
2021
Q3 | $462K | Sell |
4,583
-478
| -9% | -$48.2K | ﹤0.01% | 3520 |
|
|
2021
Q2 | $716K | Sell |
5,061
-13,413
| -73% | -$1.9M | ﹤0.01% | 3001 |
|
|
2021
Q1 | $1.84M | Buy |
18,474
+5,400
| +41% | +$538K | ﹤0.01% | 1740 |
|
|
2020
Q4 | $1.62M | Sell |
13,074
-46,015
| -78% | -$5.69M | ﹤0.01% | 1658 |
|
|
2020
Q3 | $5.76M | Buy |
59,089
+7,543
| +15% | +$735K | ﹤0.01% | 543 |
|
|
2020
Q2 | $8.04M | Buy |
51,546
+30,592
| +146% | +$4.77M | 0.01% | 461 |
|
|
2020
Q1 | $3.02M | Buy |
20,954
+16,587
| +380% | +$2.39M | ﹤0.01% | 791 |
|
|
2019
Q4 | $893K | Buy |
+4,367
| New | +$893K | ﹤0.01% | 1680 |
|
|
2019
Q2 | – | Sell |
-2,758
| Closed | -$236K | – | 4122 |
|
|
2019
Q1 | $236K | Buy |
+2,758
| New | +$236K | ﹤0.01% | 2877 |
|